Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-12-02 Sale | 2024-12-03 4:05 pm | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Commercial Officer | 7,500 | $8.9431 | $67,073 | 236,950 (Direct) | View |
2024-09-03 Sale | 2024-09-05 4:42 pm | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Commercial Officer | 7,500 | $7.2232 | $54,174 | 255,881 (Direct) | View |
2024-06-11 Sale | 2024-06-12 4:25 pm | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Commercial Officer | 7,500 | $6.5344 | $49,008 | 266,153 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-12-01 Tax Withholding | 2024-12-03 4:05 pm | N/A N/A | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Commercial Officer | 11,431 | $8.9732 | 236,950 (Direct) | View |
2024-09-03 Tax Withholding | 2024-09-05 4:42 pm | N/A N/A | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Commercial Officer | 2,772 | $7.2691 | 255,881 (Direct) | View |
2024-06-03 Tax Withholding | 2024-06-04 4:13 pm | N/A N/A | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Commercial Officer | 2,951 | $6.5333 | 273,653 (Direct) | View |
2024-03-01 Tax Withholding | 2024-03-05 4:14 pm | N/A N/A | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Commercial Officer | 4,540 | $8.0512 | 276,604 (Direct) | View |
2024-02-20 Option Award | 2024-02-22 7:34 pm | N/A N/A | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Commercial Officer | 113,334 | $0 | 281,144 (Direct) | View |
2023-12-01 Tax Withholding | 2023-12-05 5:38 pm | N/A N/A | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Commercial Officer | 2,921 | $7.4503 | 167,810 (Direct) | View |
2023-09-01 Tax Withholding | 2023-09-06 8:46 pm | N/A N/A | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Commercial Officer | 8,460 | $11.78 | 170,731 (Direct) | View |
2023-06-01 Tax Withholding | 2023-06-05 7:32 pm | N/A N/A | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Commercial Officer | 1,038 | $11.24 | 179,191 (Direct) | View |
2023-03-01 Tax Withholding | 2023-03-03 5:09 pm | N/A N/A | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Commercial Officer | 1,569 | $14.29 | 180,929 (Direct) | View |
2023-03-01 Option Award | 2023-03-03 5:09 pm | N/A N/A | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Commercial Officer | 3,083 | $0 | 180,929 (Direct) | View |
2022-12-01 Tax Withholding | 2022-12-05 4:38 pm | N/A N/A | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Growth Officer | 2,446 | $10.65 | 179,415 (Direct) | View |
2022-09-08 Option Award | 2022-09-12 6:13 pm | N/A N/A | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Growth Officer | 120,000 | $0 | 181,861 (Direct) | View |
Ownership | 2022-09-12 6:10 pm | N/A N/A | Health Catalyst Inc. | HCAT | Freeman Kevin Lee Chief Growth Officer | 0 | $0 | 181,161 (Direct) | View |